Table 1.
WBC count* (×103/μL) | Neutrophil count* (×103/μL) | Lymphocyte count* (×103/μL) | NLR* | |
---|---|---|---|---|
Group A (n=125) | 7.600 (1.300–18.000) | 4.600 (600–13.000) | 2.000 (500–5.600) | 2.24 (0.81–11.67) |
Group B (n=217) | 7.300 (2.600–20.000) | 4.400 (570–18.000) | 2.100 (520–10.000) | 2.05 (0.27–10.00) |
Group C (n=20) | 6.400 (2.800–16.500) | 4.050 (1.700–14.700) | 1.700 (580–3.100) | 2.34 (0.83–14.70) |
Group D (n=35) | 8.000 (3.500–16.000) | 5.700 (1.800–13.000) | 1.700 (860–3.700) | 3.25 (0.81–10.00) |
p** | 0.263 | 0.158 | 0.002 | 0.007 |
Meaningful comparisons# | None | 2 & 4 | 1 & 4, 2 & 3, 2 & 4 | 1 & 4, 2 & 4 |
WBC – white blood cell; NLR – neutrophil lymphocyte ratio, Group A – hyperplastic polips; Group B – adenomatous polyps; Group C – adenomatous Polyps with dysplasi; Group D – polyps with adenocancer.
All values are given as median (min-max range);
Comparasions was done by Kruskal Wallis test;
Comparasions was done by Man Whitney U test.